A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT00901979 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 693
Last updated 2013-01-09
Summary
This study will assess the effect of LCQ when added to metformin.
Conditions
Interventions
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
- Canada
- Italy
- Poland
- Puerto Rico
Study Locations
More Related Trials
-
A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
NCT00830076 ·Status: COMPLETED ·Phase: PHASE1
-
MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
NCT00103857 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lobeglitazone Versus Sitagliptin
NCT02480465 ·Status: UNKNOWN ·Phase: PHASE4
-
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
NCT07019012 ·Status: RECRUITING ·Phase: PHASE4
-
Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes
NCT01933672 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
NCT00820573 ·Status: COMPLETED ·Phase: PHASE4
-
Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
NCT01099618 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
NCT01076075 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
NCT00127192 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
NCT02284893 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
NCT00734474 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
NCT01602003 ·Status: COMPLETED ·Phase: PHASE3
-
30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
NCT01028391 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
NCT00813995 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
NCT00704132 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
NCT00760344 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
NCT02111096 ·Status: TERMINATED ·Phase: PHASE2
-
Sitagliptin and Glucagon Counterregulation
NCT02256189 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
NCT02250794 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin
NCT00960453 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
NCT02791490 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2
NCT07076056 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
NCT00449930 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
NCT00975052 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
NCT02532855 ·Status: COMPLETED ·Phase: PHASE3